RLMD vs. ATRA

Last updated Jun 23, 2026

RLMD (Relmada Therapeutics, Inc.) and ATRA (Atara Biotherapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, RLMD returned -3.73%/yr vs -32.46%/yr for ATRA. At a 0.14 correlation, their price movements are largely independent.

Performance

RLMD vs. ATRA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Relmada Therapeutics, Inc. (RLMD) and Atara Biotherapeutics, Inc. (ATRA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RLMD achieves a 42.65% return, which is significantly higher than ATRA's -41.35% return. Over the past 10 years, RLMD has outperformed ATRA with an annualized return of -3.73%, while ATRA has yielded a comparatively lower -32.46% annualized return.

RLMD

• 1D: 2.38%
• 1M: -2.13%
• YTD: 42.65%
• 6M: 53.45%
• 1Y: 915.48%
• 3Y*: 40.77%
• 5Y*: -26.52%
• 10Y*: -3.73%

ATRA

• 1D: 5.36%
• 1M: 8.27%
• YTD: -41.35%
• 6M: -40.59%
• 1Y: 33.63%
• 3Y*: -37.76%
• 5Y*: -51.30%
• 10Y*: -32.46%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RLMD vs. ATRA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RLMD Relmada Therapeutics, Inc.	42.65%	828.85%	-87.44%	18.62%	-84.51%	-29.75%	-17.77%	747.83%	53.33%	-31.19%
ATRA Atara Biotherapeutics, Inc.	-41.35%	35.91%	3.82%	-84.37%	-79.19%	-19.71%	19.19%	-52.59%	91.93%	27.46%

Correlation

The correlation between RLMD and ATRA is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.27
Correlation (3Y) Calculated over the trailing 3-year period	0.16
Correlation (5Y) Calculated over the trailing 5-year period	0.24
Correlation (10Y) Calculated over the trailing 10-year period	0.17
Correlation (All Time) Calculated using the full available price history since Oct 16, 2014	0.14

The correlation between RLMD and ATRA shifts across timeframes, from 0.14 (all time) to 0.27 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap RLMD : $596.65M ATRA : $149.40M
EPS RLMD : -$1.06 ATRA : -$0.72
Total Revenue (TTM) RLMD : $0.00 ATRA : $22.62M
Gross Profit (TTM) RLMD : $0.00 ATRA : $21.73M
EBITDA (TTM) RLMD : -$60.34M ATRA : -$6.92M

Return for Risk

RLMD vs. ATRA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RLMD

RLMD Risk / Return Rank: 99
RLMD Sharpe Ratio Rank: 100
RLMD Sortino Ratio Rank: 99
RLMD Omega Ratio Rank: 97
RLMD Calmar Ratio Rank: 100
RLMD Martin Ratio Rank: 100

ATRA

ATRA Risk / Return Rank: 59
ATRA Sharpe Ratio Rank: 51
ATRA Sortino Ratio Rank: 67
ATRA Omega Ratio Rank: 74
ATRA Calmar Ratio Rank: 52
ATRA Martin Ratio Rank: 51

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RLMD vs. ATRA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Relmada Therapeutics, Inc. (RLMD) and Atara Biotherapeutics, Inc. (ATRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RLMD	ATRA	Difference
Sharpe ratio: Return per unit of total volatility	7.54	0.24	+7.31
Sortino ratio: Return per unit of downside risk	5.86	1.52	+4.35
Omega ratio: Gain probability vs. loss probability	1.65	1.24	+0.41
Calmar ratio: Return relative to maximum drawdown	33.70	0.44	+33.26
Martin ratio: Return relative to average drawdown	75.27	0.76	+74.52

RLMD vs. ATRA - Sharpe Ratio Comparison

The current RLMD Sharpe Ratio is 7.54, which is higher than the ATRA Sharpe Ratio of 0.24. The chart below compares the historical Sharpe Ratios of RLMD and ATRA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RLMD vs. ATRA - Drawdown Comparison

The maximum RLMD drawdown since its inception was -99.66%, roughly equal to the maximum ATRA drawdown of -99.74%. Use the drawdown chart below to compare losses from any high point for RLMD and ATRA.

Drawdown Indicators

	RLMD	ATRA	Difference
Max Drawdown Largest peak-to-trough decline	-99.66%	-99.74%	+0.08%
Max Drawdown (1Y) Largest decline over 1 year	-27.44%	-76.89%	+49.45%
Max Drawdown (3Y) Largest decline over 3 years	-96.30%	-92.76%	-3.54%
Max Drawdown (5Y) Largest decline over 5 years	-99.32%	-99.16%	-0.16%
Max Drawdown (10Y) Largest decline over 10 years	-99.50%	-99.68%	+0.18%
Current Drawdown Current decline from peak	-90.74%	-99.34%	+8.60%
Average Drawdown Average peak-to-trough decline	-79.72%	-74.07%	-5.65%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.39%	44.48%	-32.09%

Volatility

RLMD vs. ATRA - Volatility Comparison

The current volatility for Relmada Therapeutics, Inc. (RLMD) is 16.62%, while Atara Biotherapeutics, Inc. (ATRA) has a volatility of 20.65%. This indicates that RLMD experiences smaller price fluctuations and is considered to be less risky than ATRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RLMD	ATRA	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.62%	20.65%	-4.03%
Volatility (6M) Calculated over the trailing 6-month period	67.85%	131.74%	-63.89%
Volatility (1Y) Calculated over the trailing 1-year period	122.87%	144.04%	-21.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	116.39%	122.04%	-5.65%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	114.22%	100.24%	+13.98%

Dividends

RLMD vs. ATRA - Dividend Comparison

Neither RLMD nor ATRA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both RLMD and ATRA in my portfolio?

RLMD and ATRA have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RLMD or ATRA?

ATRA has higher volatility (20.65%) compared to RLMD (16.62%). In terms of maximum drawdown, RLMD dropped -99.66% vs ATRA's -99.74%.

Which has better risk-adjusted returns?

RLMD currently has the higher Sharpe Ratio (7.54 vs 0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.